Position in UTHR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,461,695
+$430,674 QoQ
Shares Held
2,465
+16.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $45,054,973 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
270,642 | $31,992,590 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
148,384 | $4,469,326 | |
| 3 | VTRS |
Viatris Inc
|
257,647 | $3,480,810 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,465 | $1,461,695 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
250,795 | $1,354,293 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
5,544 | $730,366 | |
| 7 | HLN |
Haleon plc
|
53,465 | $535,184 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
15,695 | $375,581 |
All Filings in UTHR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,461,695 | 2,465 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,031,021 | 2,116 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $681,635 | 1,626 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $480,161 | 1,671 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $516,043 | 1,674 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $563,838 | 1,598 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $549,350 | 1,533 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $489,929 | 1,538 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $299,554 | 1,304 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $286,736 | 1,304 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $294,534 | 1,304 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $289,403 | 1,311 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $292,043 | 1,304 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $325,921 | 1,172 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $365,158 | 1,744 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $410,956 | 1,744 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $335,676 | 1,871 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $404,285 | 1,871 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $335,197 | 1,816 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $299,614 | 1,670 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $279,340 | 1,670 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $249,998 | 1,647 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||